FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used as a combined treatment of giant cell tumor. That is ensured by two courses of 120 mg densumab before the surgical treatment once a month as a neoadjuvant target therapy of the patients with giant cell tumor. Therapeutic course involves administering 120 mg of the preparation once a month.
EFFECT: invention enables to reduce tumor size; proposed method of treatment promotes adhesion of pathological fractures, restoration of function of adjacent joints, causes sclerosis and pathomorphosis of tumor tissue in patients with giant cell bone tumor.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OPTIMISING PREOPERATIVE THERAPY OF GIANT CELL TUMOUR OF BONE | 2021 |
|
RU2782139C1 |
| METHOD FOR SURGICAL TREATMENT OF GIANT CELL TUMOUR OF KNEE JOINT BONES | 2024 |
|
RU2822230C1 |
| METHOD OF ANTITUMOUR IMMUNOTHERAPY | 2012 |
|
RU2530523C2 |
| METHOD FOR TREATMENT OF PLURAL OSTEAL METASTASISES DURING MAMMARY GLAND CANCER | 2007 |
|
RU2332992C1 |
| METHOD FOR PREDICTING CHILDREN BONE CYST DEVELOPMENT COURSE UNDER VARIOUS TYPES OF TREATMENT | 1997 |
|
RU2121677C1 |
| METHOD OF INCREASING BONE MINERAL DENSITY IN PATIENTS WITH OSTEOPOROSIS AND POLYNEUROPATHY IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2804251C1 |
| METHOD FOR ACCELERATED REGENERATION OF BONE IN CONDUCTING OSTEOSYNTETHESIS | 2009 |
|
RU2410050C2 |
| METHOD FOR PREDICTING TREATMENT RESULTS OF EMBRYONIC TUMOURS | 2021 |
|
RU2760168C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT AUTOMYELOCHEMOTHERAPY IN PATIENTS WITH RECURRENT BREAST CANCER | 2008 |
|
RU2393484C1 |
| METHOD OF TREATING CHRONIC OSTEOMYELITIS WITH BONE DEFECT | 2008 |
|
RU2389442C1 |
